Inflammatory protein signatures associated with high rivaroxaban exposure.

Direct oral anticoagulants, including rivaroxaban, are widely prescribed for the prevention and treatment of thromboembolic disorders. Despite generally predictable pharmacokinetics (PK), real-world data reveal striking interindividual variability in…

Preview only. Read the full abstract at the source